Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

Lancet Respiratory Medicine,The - Tập 12 - Trang 34-44 - 2024
Göran Dellgren1,2, Thomas Kromann Lund3, Peter Raivio4, Inga Leuckfeld5, Johan Svahn6, Erik C Holmberg7, Peter Skov Olsen8, Maija Halme9, Arnt Fiane10,11, Sandra Lindstedt12, Gerdt C Riise2,13, Jesper Magnusson2,13
1Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
2Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
3Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
4Department of Cardiac Surgery, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
5Department of Respiratory Medicine, Oslo University Hospital, Oslo, Norway
6Department of Pulmonology and Allergology, Skåne University Hospital, Lund, Sweden
7Department of Oncology, Institute of Clinical Sciences, University of Gothenburg, Sweden
8Department of Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
9Department of Pulmonology, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
10Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway
11Faculty of Medicine, University of Oslo, Oslo, Norway
12Department of Cardiothoracic Surgery, Skåne University Hospital, Lund, Sweden
13Department of Pulmonology, Sahlgrenska University Hospital, Gothenburg, Sweden

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Lancet Respiratory Medicine,The

Tập 12

34-44

Thông tin tác giả